We have observed an electrophoreticaliy abnormal, nonfunctional species of a1 -antitrypsin in serum from patients who were receiving bone-marrow transplants for treatment of leukemia or aplastic anemia. Three of four patients in whose serum this protein appeared died soon after; the fourth recovered, and the disappearance of the abnormal a1-antitrypsin paralleled his recovery. This suggests that the inability to maintain functional activity of a1-antitrypsin predisposes patients to life-threatening complications during recovery from bone-marrow transplants. 
